ARCARI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 71
AS - Asia 22
EU - Europa 9
AF - Africa 3
Totale 105
Nazione #
US - Stati Uniti d'America 71
SG - Singapore 22
IT - Italia 8
DZ - Algeria 2
AT - Austria 1
ZA - Sudafrica 1
Totale 105
Città #
Boardman 25
Singapore 22
Chicago 18
Santa Clara 6
Assago 4
Djelfa 2
Como 1
Gorgonzola 1
Varese 1
Vienna 1
Totale 81
Nome #
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations 9
Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared 9
Ceftazidime-avibactam resistance in Klebsiella pneumoniae sequence type 37: a decade of persistence and concealed evolution 8
Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem. A case report 8
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality 8
In vitro activity of fosfomycin against mucoid and non-mucoid Pseudomonas aeruginosa strains 8
Meropenem-Vaborbactam as salvage therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae-producing KPC-31, a D179Y variant of KPC-3 7
An outbreak sustained by ST15 Klebsiella pneumoniae carrying 16S rRNA methyltransferases and blaNDM: evaluation of the global dissemination of these resistance determinants 7
Klebsiella pneumoniae infections in COVID-19 patients: a two-month retrospective analysis in an Italian hospital 7
Genetic background of neomycin resistance in clinical Escherichia coli isolated from Danish pig farms 7
Corynebacterium ramonii sp. nov., a novel toxigenic member of the Corynebacterium diphtheriae species complex 7
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21 7
Genome-based retrospective analysis of a Providencia stuartii outbreak in Rome, Italy. Broad spectrum IncC plasmids spread the NDM carbapenemase within the hospital 7
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience 7
Evolutionary trajectories toward ceftazidime-avibactam resistance in Klebsiella pneumoniae clinical isolates 7
Global spread and evolutionary convergence of multidrug-resistant and hypervirulent Klebsiella pneumoniae high-risk clones 7
Corynebacteria of the diphtheriae Species Complex in Companion Animals: Clinical and Microbiological Characterization of 64 Cases from France 7
Genotypic evolution of Klebsiella pneumoniae sequence type 512 during ceftazidime/avibactam, meropenem/vaborbactam, and cefiderocol treatment, Italy 7
Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017-2019 6
Multidrug-resistant toxigenic Corynebacterium diphtheriae sublineage 453 with two novel resistance genomic islands 6
Beyond appearance: An unusual manifestation of isolated oral secondary syphilis 6
Multiplicity of blaKPC genes and pKpQIL plasmid plasticity in the development of ceftazidime-avibactam and Meropenem coresistance in Klebsiella pneumoniae sequence type 307 5
Virulence plasmid pINV as a genetic signature for Shigella flexneri phylogeny 5
A multi-species bunch of VIM-1 Carbapenemase producing enterobacterales linked by a novel, highly conjugative and broad-host range IncA plasmid, menaces the re-emergence of VIM-1 4
In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512 3
Totale 169
Categoria #
all - tutte 1.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202471 0 0 0 0 0 0 0 0 0 63 4 4
2024/202598 0 0 97 1 0 0 0 0 0 0 0 0
Totale 169